Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1999 2
2003 11
2004 19
2005 7
2006 12
2007 6
2008 8
2009 6
2010 3
2011 1
2012 4
2013 1
2014 2
2015 10
2016 5
2017 3
2018 2
2019 3
2020 4
2021 6
2022 10
2023 10
2024 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

143 results

Results by year

Filters applied: . Clear all
Page 1
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
Diabetic Retinopathy Clinical Research Network; Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW. Diabetic Retinopathy Clinical Research Network, et al. N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18. N Engl J Med. 2015. PMID: 25692915 Free PMC article. Clinical Trial.
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.
Jhaveri CD, Glassman AR, Ferris FL 3rd, Liu D, Maguire MG, Allen JB, Baker CW, Browning D, Cunningham MA, Friedman SM, Jampol LM, Marcus DM, Martin DF, Preston CM, Stockdale CR, Sun JK; DRCR Retina Network. Jhaveri CD, et al. N Engl J Med. 2022 Aug 25;387(8):692-703. doi: 10.1056/NEJMoa2204225. Epub 2022 Jul 14. N Engl J Med. 2022. PMID: 35833805 Free PMC article. Clinical Trial.
Neurological Complications of Cannabinoids.
Humayun M, Suarez JI, Shah VA. Humayun M, et al. Among authors: shah va. Semin Neurol. 2024 Aug;44(4):430-440. doi: 10.1055/s-0044-1787570. Epub 2024 Jun 24. Semin Neurol. 2024. PMID: 38914126 Review.
One-Year Outcome Trajectories and Factors Associated with Functional Recovery Among Survivors of Intracerebral and Intraventricular Hemorrhage With Initial Severe Disability.
Shah VA, Thompson RE, Yenokyan G, Acosta JN, Avadhani R, Dlugash R, McBee N, Li Y, Hansen BM, Ullman N, Falcone G, Awad IA, Hanley DF, Ziai WC. Shah VA, et al. JAMA Neurol. 2022 Sep 1;79(9):856-868. doi: 10.1001/jamaneurol.2022.1991. JAMA Neurol. 2022. PMID: 35877105 Free PMC article.
Talc retinopathy.
Shah VA, Cassell M, Poulose A, Sabates NR. Shah VA, et al. Ophthalmology. 2008 Apr;115(4):755-755.e2. doi: 10.1016/j.ophtha.2007.10.043. Ophthalmology. 2008. PMID: 18387416 No abstract available.
Hydroxychloroquine retinopathy: A review of imaging.
Pandya HK, Robinson M, Mandal N, Shah VA. Pandya HK, et al. Among authors: shah va. Indian J Ophthalmol. 2015 Jul;63(7):570-4. doi: 10.4103/0301-4738.167120. Indian J Ophthalmol. 2015. PMID: 26458473 Free PMC article. Review.
Smartphones in ophthalmology.
Chhablani J, Kaja S, Shah VA. Chhablani J, et al. Among authors: shah va. Indian J Ophthalmol. 2012 Mar-Apr;60(2):127-31. doi: 10.4103/0301-4738.94054. Indian J Ophthalmol. 2012. PMID: 22446908 Free PMC article.
Outcome Trajectories after Intracerebral Hemorrhage.
Carhuapoma L, Murthy S, Shah VA. Carhuapoma L, et al. Among authors: shah va. Semin Neurol. 2024 Jun;44(3):298-307. doi: 10.1055/s-0044-1787104. Epub 2024 May 24. Semin Neurol. 2024. PMID: 38788763 Review.
Idiopathic intracranial hypertension.
Shah VA, Fung S, Shahbaz R, Taktakishvili O, Wall M, Lee AG. Shah VA, et al. Ophthalmology. 2007 Mar;114(3):617. doi: 10.1016/j.ophtha.2006.08.034. Ophthalmology. 2007. PMID: 17324704 No abstract available.
143 results